Document Detail


Modelling the hepatitis C virus epidemic in Australia. Hepatitis C Virus Projections Working Group.
MedLine Citation:
PMID:  10574138     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: In Australia, to the end of 1997, more than 110,000 people have been diagnosed with hepatitis C virus (HCV) antibodies and reported to State/Territory surveillance systems. The available data indicate that the overwhelming majority (around 80%) of people with HCV antibodies were infected through injecting drug use. METHODS: Models of the HCV epidemic in Australia were developed based on estimates of the pattern of injecting drug use in Australia. Estimates of HCV infections due to injecting drug use thus obtained were then adjusted to allow for HCV infections resulting from other transmission routes. Projections of cirrhosis and hepatocellular carcinoma (HCC) resulting from HCV were obtained by combining modelled HCV incidence with estimates of the progression rates to these outcomes. RESULTS: Based on the models, it was estimated that there were 196,000 (lower and upper limits of 149,000 and 234,000) people in Australia living with HCV antibodies at the end of 1997, with HCV incidence in 1997 estimated to be 11,000 (8500-13,500). It was estimated that 8500 (4000-13,000) people were living with HCV-related cirrhosis in 1997 and that there were 80 (40-125) incident cases of HCV-related HCC. DISCUSSION: Model-based estimates were broadly consistent with other sources of information on the HCV epidemic in Australia. These models suggest that the prevalence of HCV-related cirrhosis and the incidence of HCV-related HCC will more than double in Australia by 2010.
Authors:
M G Law
Related Documents :
19440928 - Hcv treatment decision-making substance use experiences and hepatitis c treatment decis...
17687818 - Hcv-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosu...
12503038 - Prevalence of hepatitis b and c seromarkers and abnormal liver function tests among hem...
11678898 - Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda.
9493518 - Interferon treatment in hepatitis b surface antigen-positive hepatitis b e antibody-pos...
4031828 - Inadequacy of immunoglobulin m hepatitis b core antibody in detecting acute hepatitis b...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of gastroenterology and hepatology     Volume:  14     ISSN:  0815-9319     ISO Abbreviation:  J. Gastroenterol. Hepatol.     Publication Date:  1999 Nov 
Date Detail:
Created Date:  2000-01-04     Completed Date:  2000-01-04     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8607909     Medline TA:  J Gastroenterol Hepatol     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  1100-7     Citation Subset:  IM    
Affiliation:
National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Darlinghurst, Australia. mlaw@nchecr.unsw.edu.au
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Australia
Carcinoma, Hepatocellular / epidemiology
Cross-Sectional Studies
Disease Outbreaks / statistics & numerical data*
Disease Progression
Hepatitis C / epidemiology,  transmission*
Humans
Incidence
Liver Cirrhosis / epidemiology
Liver Neoplasms / epidemiology
Models, Statistical*
Population Surveillance
Substance Abuse, Intravenous / epidemiology*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, place...
Next Document:  Mixed cryoglobulinaemia associated with hepatitis C virus infection: a predictor factor for treatmen...